Core Laboratories financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$427.43M $483.47M $575.69M $670.54M $780.84M $695.54M $794.65M $907.65M $981.08M $1.07B $1.09B $797.52M $590.23M $647.82M $700.85M $668.21M $487.27M $470.25M $489.74M $509.79M $0.00M
GM % Gross Margin %
21.30% 23.86% 29.28% 33.01% 34.07% 34.18% 35.34% 34.63% 36.62% 38.24% 38.70% 33.21% 25.88% 28.23% 29.09% 25.83% 20.96% 21.77% 19.62% 21.54% 0.00%
OM Operating Margin
10.84% 12.54% 20.87% 25.59% 26.95% 26.43% 28.59% 27.69% 29.93% 31.14% 32.15% 23.53% 14.93% 17.19% 17.10% 15.27% 10.18% 8.78% 8.79% 11.06% 0.00%
EPS Earnings Per Share
$3.02 $2.08 $1.78 $0.79 $0.71 $0.57 $0.80 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.98 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.20 $0.28 $0.04 $0.04 $0.04 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 123.60% 35.44% 5.63% 7.02% 5.00% 0
Sha. Shares
52.58m 51.69m 50.18m 46.69m 46.04m 45.96m 44.92m 46.63m 46.66m 45.37m 43.8m 42.37m 44.11m 44.15m 44.22m 44.37m 44.48m 44.49m 46.28m 46.72m 46.72m
OCF Operating Cash Flow
$54.20M $74.78M $120.31M $125.70M $155.21M $181.87M $205.83M $204.13M $237.20M $298.14M $303.45M $219.10M $131.89M $124.27M $111.83M $89.53M $57.87M $36.58M $24.96M $24.79M $0.00M
FCF Free Cash Flow
$43.31M $55.68M $95.89M $101.87M $124.26M $164.58M $178.26M $174.20M $206.05M $262.72M $266.86M $196.30M $120.53M $105.50M $90.09M $67.26M $45.99M $23.04M $14.74M $35.05M $0.00M
FCFS Free Cash Flow Per Share
$0.80 $1.07 $1.90 $2.16 $2.69 $3.58 $3.97 $3.76 $4.33 $5.67 $6.00 $4.56 $2.76 $2.38 $2.01 $1.51 $1.02 $0.49 $0.32 $0.31 $0.00